Bioscience

UA Cancer Center awarded $9.6 million

November 12, 2012

By Flinn Foundation

From: UA Cancer Center News Release

The University of Arizona Early Phase Chemoprevention Consortium led by UA Cancer Center researchers has been awarded $9.6 million over five years by the National Cancer Institute to conduct early-phase clinical trials to evaluate the safety, clinical activity, and biological effects of novel cancer preventive agents.

Read More: UA Cancer Center awarded $9.6 million for studies